[HTML][HTML] Thrombus-targeting polymeric nanocarriers and their biomedical applications in thrombolytic therapy

Q Guan, H Dou - Frontiers in physiology, 2021 - frontiersin.org
Due to the high morbidity and mortality of cardiovascular diseases, there is an urgent need
for research on antithrombotic strategies. In view of the short half-life, insufficient drug …

[HTML][HTML] Thrombus-Targeting Polymeric Nanocarriers and Their Biomedical Applications in Thrombolytic Therapy

Q Guan, H Dou - Frontiers in Physiology, 2021 - ncbi.nlm.nih.gov
Due to the high morbidity and mortality of cardiovascular diseases, there is an urgent need
for research on antithrombotic strategies. In view of the short half-life, insufficient drug …

[HTML][HTML] Thrombus-Targeting Polymeric Nanocarriers and Their Biomedical Applications in Thrombolytic Therapy

Q Guan, H Dou - Frontiers in Physiology, 2021 - frontiersin.org
Due to the high morbidity and mortality of cardiovascular diseases, there is an urgent need
for research on antithrombotic strategies. In view of the short half-life, insufficient drug …

Thrombus-Targeting Polymeric Nanocarriers and Their Biomedical Applications in Thrombolytic Therapy

Q Guan, H Dou - Metabolism and Vascular Diseases, 2022 - books.google.com
Thrombus-Targeting Polymeric Nanocarriers and Their Biomedical Applications in
Thrombolytic Therapy Page 58 MINI REVIEW published: 30 November 2021 doi: 10.3389/fphys …

Thrombus-Targeting Polymeric Nanocarriers and Their Biomedical Applications in Thrombolytic Therapy

Q Guan, H Dou - Frontiers in physiology, 2021 - pubmed.ncbi.nlm.nih.gov
Due to the high morbidity and mortality of cardiovascular diseases, there is an urgent need
for research on antithrombotic strategies. In view of the short half-life, insufficient drug …

Thrombus-Targeting Polymeric Nanocarriers and Their Biomedical Applications in Thrombolytic Therapy.

Q Guan, H Dou - Frontiers in Physiology, 2021 - europepmc.org
Due to the high morbidity and mortality of cardiovascular diseases, there is an urgent need
for research on antithrombotic strategies. In view of the short half-life, insufficient drug …